Streptococcus suis Capsular Polysaccharide Inhibits Phagocytosis through Destabilization of Lipid Microdomains and Prevents Lactosylceramide-Dependent Recognition
Authors:
- 1 February 2012
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 80 (2) , 506-517
Abstract
Streptococcus suis type 2 is a major swine pathogen and a zoonotic agent, causing meningitis in both swine and humans. S. suis infects the host through the respiratory route, reaches the bloodstream, and persists until breaching into the central nervous system. The capsular polysaccharide (CPS) of S. suis type 2 is considered a key virulence factor of the bacteria. Though CPS allows S. suis to adhere to the membrane of cells of the immune system, it provides protection against phagocytosis. In fact, nonencapsulated mutants are easily internalized and killed by macrophages and dendritic cells. The objective of this work was to study the molecular mechanisms by which the CPS of S. suis prevents phagocytosis. By using latex beads covalently linked with purified CPS, it was shown that CPS itself was sufficient to inhibit entry of both latex beads and bystander fluorescent beads into macrophages. Upon contact with macrophages, encapsulated S. suis was shown to destabilize lipid microdomains at the cell surface, to block nitric oxide (NO) production during infection, and to prevent lactosylceramide accumulation at the phagocytic cup during infection. In contrast, the nonencapsulated mutant was easily internalized via lipid rafts, in a filipin-sensitive manner, leading to lactosylceramide recruitment and strong NO production. This is the first report to identify a role for CPS in lipid microdomain stability and to recognize an interaction between S. suis and lactosylceramide in phagocytes.Keywords
This publication has 52 references indexed in Scilit:
- Characterization of porcine dendritic cell response to Streptococcus suisVeterinary Research, 2011
- In VitroCharacterization of the Microglial Inflammatory Response toStreptococcus suis, an Important Emerging Zoonotic Agent of MeningitisInfection and Immunity, 2010
- Host‐cell lipid rafts: a safe door for micro‐organisms?Biology of the Cell, 2010
- Activated Dectin-1 Localizes to Lipid Raft Microdomains for Signaling and Activation of Phagocytosis and Cytokine Production in Dendritic CellsJournal of Biological Chemistry, 2009
- Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune responseBlood, 2009
- Group B streptococcus exploits lipid rafts and phosphoinositide 3-kinase/Akt signaling pathway to invade human endometrial cellsAmerican Journal of Obstetrics and Gynecology, 2008
- Lipid raft-dependent uptake, signalling and intracellular fate ofPorphyromonas gingivalisin mouse macrophagesCellular Microbiology, 2008
- Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switchingProceedings of the National Academy of Sciences, 2008
- Streptococcus suisSequence Type 7 Outbreak, Sichuan, ChinaEmerging Infectious Diseases, 2006
- The Major Subunit, CfaB, of Colonization Factor Antigen I from Enterotoxigenic Escherichia coli Is a Glycosphingolipid Binding ProteinInfection and Immunity, 2006